DD137355A5 - Verfahren zur herstellung von phthalazin-derivaten - Google Patents

Verfahren zur herstellung von phthalazin-derivaten

Info

Publication number
DD137355A5
DD137355A5 DD78205751A DD20575178A DD137355A5 DD 137355 A5 DD137355 A5 DD 137355A5 DD 78205751 A DD78205751 A DD 78205751A DD 20575178 A DD20575178 A DD 20575178A DD 137355 A5 DD137355 A5 DD 137355A5
Authority
DD
German Democratic Republic
Prior art keywords
preparation
phthalazine derivatives
phthalazine
derivatives
Prior art date
Application number
DD78205751A
Other languages
German (de)
English (en)
Inventor
Simon F Campbell
John C Danilewicz
Anthony G Evans
Allan L Ham
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DD137355A5 publication Critical patent/DD137355A5/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
DD78205751A 1977-06-03 1978-06-02 Verfahren zur herstellung von phthalazin-derivaten DD137355A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2358277 1977-06-03

Publications (1)

Publication Number Publication Date
DD137355A5 true DD137355A5 (de) 1979-08-29

Family

ID=10198020

Family Applications (1)

Application Number Title Priority Date Filing Date
DD78205751A DD137355A5 (de) 1977-06-03 1978-06-02 Verfahren zur herstellung von phthalazin-derivaten

Country Status (29)

Country Link
US (1) US4289772A (es)
JP (1) JPS5416488A (es)
AR (2) AR222013A1 (es)
AT (2) AT362792B (es)
AU (1) AU505373B1 (es)
BE (1) BE867727A (es)
CA (1) CA1111850A (es)
DD (1) DD137355A5 (es)
DE (1) DE2824064A1 (es)
DK (1) DK248078A (es)
EG (1) EG13527A (es)
ES (4) ES470470A1 (es)
FI (1) FI781753A (es)
FR (1) FR2392986A1 (es)
GB (1) GB2000136B (es)
GR (1) GR74402B (es)
HU (1) HU179745B (es)
IL (1) IL54842A (es)
IN (3) IN148482B (es)
IT (1) IT1094944B (es)
LU (1) LU79761A1 (es)
NL (1) NL7806016A (es)
NO (1) NO781935L (es)
NZ (1) NZ187453A (es)
PL (3) PL116420B1 (es)
PT (1) PT68126A (es)
SE (1) SE7806519L (es)
SU (2) SU856383A3 (es)
ZA (1) ZA783183B (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
IL59619A0 (en) * 1979-03-28 1980-06-30 Pfizer Phthalazine derivatives,their preparation and pharmaceutical compositions containing them
PL135545B1 (en) * 1980-03-01 1985-11-30 Wyeth John & Brother Ltd Process for preparing novel derivatives of piperidine
GB8320958D0 (en) * 1983-08-03 1983-09-07 Pfizer Ltd Quinazoline cardiac stimulants
US5001125A (en) * 1984-03-26 1991-03-19 Janssen Pharmaceutica N.V. Anti-virally active pyridazinamines
US4882354A (en) * 1987-12-16 1989-11-21 Norwich Eaton Pharmaceuticals, Inc. N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
US5300515A (en) * 1991-01-31 1994-04-05 Kyorin Pharmaceutical Co., Ltd. Carbamic acid derivatives and method for preparing the same
JP3169188B2 (ja) * 1991-01-31 2001-05-21 杏林製薬株式会社 カルバミン酸誘導体及びその製造方法
EP0621267A1 (en) * 1993-04-07 1994-10-26 Shell Internationale Researchmaatschappij B.V. Spiropiperidine derivatives and their use as fungicides
US5728712A (en) * 1995-05-19 1998-03-17 Chiroscience Limited 3,4-disubstituted-phenylsulphonamides and their therapeutic use
WO1998007430A1 (fr) * 1996-08-20 1998-02-26 Eisai Co., Ltd. Medicament contre les defaillances de l'erection, renfermant un compose a base de pyridazine fondue
US20030186963A1 (en) 2001-09-14 2003-10-02 Dorwald Florencio Zaragoza Substituted piperidines
ATE489378T1 (de) * 2002-08-16 2010-12-15 Janssen Pharmaceutica Nv Piperidinylverbindungen, die selektiv an integrine binden
US20040224986A1 (en) 2002-08-16 2004-11-11 Bart De Corte Piperidinyl targeting compounds that selectively bind integrins
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
TW200630337A (en) 2004-10-14 2006-09-01 Euro Celtique Sa Piperidinyl compounds and the use thereof
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
CA2620333A1 (en) 2005-08-26 2007-03-01 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
CA2625153A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by pde inhibition
EP1942879A1 (en) 2005-10-31 2008-07-16 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
BRPI0707223A2 (pt) * 2006-01-27 2011-04-26 Pfizer Prod Inc compostos de derivados de aminoftalazina
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US8247442B2 (en) 2006-03-29 2012-08-21 Purdue Pharma L.P. Benzenesulfonamide compounds and their use
TW200812963A (en) 2006-04-13 2008-03-16 Euro Celtique Sa Benzenesulfonamide compounds and the use thereof
TW200815353A (en) 2006-04-13 2008-04-01 Euro Celtique Sa Benzenesulfonamide compounds and their use
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド アンジオテンシン調節による神経新生
JP2009536667A (ja) 2006-05-09 2009-10-15 ブレインセルス,インコーポレイティド 5ht受容体介在性の神経新生
EP1900731A1 (de) * 2006-09-07 2008-03-19 Bayer Schering Pharma Aktiengesellschaft N-(1-Phthalazin-1-yl-piperidin-4-yl)-amide als EP2-Rezeptor Modulatoren
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US8399486B2 (en) 2007-04-09 2013-03-19 Purdue Pharma L.P. Benzenesulfonyl compounds and the use thereof
BRPI0815658A2 (pt) 2007-08-07 2015-02-18 Hoffmann La Roche Aril-éter pirrolidina como antagonistas do receptor nk3
CN101861302A (zh) 2007-08-22 2010-10-13 弗·哈夫曼-拉罗切有限公司 作为nk3受体拮抗剂的吡咯烷芳基-醚
CN101801927A (zh) * 2007-09-14 2010-08-11 弗·哈夫曼-拉罗切有限公司 作为nk3受体拮抗剂的哌啶衍生物
US8765736B2 (en) 2007-09-28 2014-07-01 Purdue Pharma L.P. Benzenesulfonamide compounds and the use thereof
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
AR077014A1 (es) * 2009-06-19 2011-07-27 Lilly Co Eli Compuesto derivado de ftalazina 1,4-disustituida, composicion farmaceutica que lo comprende y uso para preparar un medicamento util para el tratamiento de cancer
US20150119399A1 (en) 2012-01-10 2015-04-30 President And Fellows Of Harvard College Beta-cell replication promoting compounds and methods of their use
CN113087654B (zh) * 2021-04-15 2022-12-23 苏州昊帆生物股份有限公司 哌啶-4-丁胺的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1094044A (en) * 1965-07-12 1967-12-06 Vantorex Ltd Phthalazine derivatives
GB1199768A (en) 1966-10-31 1970-07-22 Pfizer & Co C Nitrogen Heterocycles and process for their preparation
GB1293565A (en) 1969-05-03 1972-10-18 Aspro Nicholas Ltd Aminophthalazines and pharmaceutical compositions thereof
GB1460389A (en) 1974-07-25 1977-01-06 Pfizer Ltd 4-substituted quinazoline cardiac stimulants

Also Published As

Publication number Publication date
AU505373B1 (en) 1979-11-15
US4289772A (en) 1981-09-15
IT7824106A0 (it) 1978-06-01
ATA400878A (de) 1980-11-15
GR74402B (es) 1984-06-28
GB2000136A (en) 1979-01-04
JPS5416488A (en) 1979-02-07
CA1111850A (en) 1981-11-03
PL116437B1 (en) 1981-06-30
IT1094944B (it) 1985-08-10
DK248078A (da) 1978-12-04
HU179745B (en) 1982-12-28
IN149550B (es) 1982-01-16
AR222013A1 (es) 1981-04-15
PL113208B1 (en) 1980-11-29
PL207337A1 (pl) 1979-06-04
AT362792B (de) 1981-06-10
ES478200A1 (es) 1980-01-01
FR2392986A1 (fr) 1978-12-29
ATA305080A (de) 1980-12-15
SU856383A3 (ru) 1981-08-15
BE867727A (fr) 1978-12-01
PL116420B1 (en) 1981-06-30
ES470470A1 (es) 1979-09-01
DE2824064A1 (de) 1978-12-14
IN148482B (es) 1981-03-07
IL54842A0 (en) 1978-08-31
AR223999A1 (es) 1981-10-15
SE7806519L (sv) 1978-12-04
SU862826A3 (ru) 1981-09-07
ES478199A1 (es) 1980-01-16
AT363096B (de) 1981-07-10
EG13527A (en) 1981-12-31
IN149973B (es) 1982-06-19
PT68126A (en) 1978-07-01
FI781753A (fi) 1978-12-04
LU79761A1 (fr) 1980-01-22
IL54842A (en) 1982-01-31
ES478201A1 (es) 1980-02-01
NO781935L (no) 1978-12-05
NL7806016A (nl) 1978-12-05
NZ187453A (en) 1980-12-19
JPS5538351B2 (es) 1980-10-03
FR2392986B1 (es) 1982-07-16
GB2000136B (en) 1982-01-06
ZA783183B (en) 1979-06-27

Similar Documents

Publication Publication Date Title
DD137355A5 (de) Verfahren zur herstellung von phthalazin-derivaten
DD138544A5 (de) Verfahren zur herstellung von cyclopropanderivaten
DD138210A5 (de) Verfahren zur herstellung von imidazolderivaten
DD138313A5 (de) Verfahren zur herstellung von alkenderivaten
DD133950A5 (de) Verfahren zur herstellung von morphinderivaten
DD133803A1 (de) Verfahren zur herstellung von furokumarinen
DD137225A5 (de) Verfahren zur herstellung von 1,2,4-triazin-5-on-derivaten
DD134090A5 (de) Verfahren zur herstellung von pyridinylaminoalkylaether
DD137595A5 (de) Verfahren zur herstellung von farbstoffen
DD137438A5 (de) Verfahren zur herstellung von n'-phenyl-n-methylharnstoffderivaten
DD135905A5 (de) Verfahren zur herstellung von harnstoffderivaten
DD135283A5 (de) Verfahren zur herstellung von neuen aminoalkoxyphenyl-derivaten
LU79591A1 (de) Verfahren zur herstellung von benzimidazol-derivaten
ATA392577A (de) Verfahren zur herstellung von acylcyaniden
DD135081A5 (de) Verfahren zur herstellung von morphinderivaten
DD132429A5 (de) Verfahren zur herstellung von derivaten von phenoxyalkansaeuren
LU79293A1 (de) Verfahren zur herstellung von chinazolin-derivaten
AT353286B (de) Verfahren zur herstellung von neuen 9- -hydroxyaethoxymethylguaninderivaten
DD130240A5 (de) Verfahren zur herstellung von acylcyaniden
DD130144A5 (de) Verfahren zur herstellung von benzoylcyanid
ATA55178A (de) Verfahren zur herstellung von 1alpha-hydroxy- -cholesterin-derivaten
DD134100A5 (de) Verfahren zur herstellung von lactamen
DD135504A5 (de) Verfahren zur herstellung von farbstoffen
DD139252A5 (de) Verfahren zur herstellung von alkylphenolen
LU78483A1 (de) Verfahren zur herstellung von benzoxazolyl-phenylstilbenen